<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0165310</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-19407</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Public and occupational health</subject><subj-group><subject>Physical activity</subject><subj-group><subject>Physical fitness</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biomechanics</subject><subj-group><subject>Biological locomotion</subject><subj-group><subject>Running</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Biological locomotion</subject><subj-group><subject>Running</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Biological locomotion</subject><subj-group><subject>Running</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical elements</subject><subj-group><subject>Oxygen</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Heredity</subject><subj-group><subject>Genetic mapping</subject><subj-group><subject>Variant genotypes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Muscle physiology</subject><subj-group><subject>Muscle contraction</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Muscle physiology</subject><subj-group><subject>Muscle contraction</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Heart rate</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological processes</subject><subj-group><subject>Respiration</subject><subj-group><subject>Oxygen consumption</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological processes</subject><subj-group><subject>Respiration</subject><subj-group><subject>Oxygen consumption</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social sciences</subject><subj-group><subject>Anthropology</subject><subj-group><subject>Physical anthropology</subject><subj-group><subject>Anthropometry</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physical anthropology</subject><subj-group><subject>Anthropometry</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>The Association of ACE Genotypes on Cardiorespiratory Variables Related to Physical Fitness in Healthy Men</article-title>
<alt-title alt-title-type="running-head">ACE Genotypes and Cardiorespiratory Variables</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Bueno</surname>
<given-names>Salomão</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Pasqua</surname>
<given-names>Leonardo A.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>de Araújo</surname>
<given-names>Gustavo</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Eduardo Lima-Silva</surname>
<given-names>Adriano</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Bertuzzi</surname>
<given-names>Rômulo</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Endurance Sports Research Group, School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Sports Science Research Group, Federal University of Alagoas, Maceió, Brazil</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Sports Science Research Group, Academic Center of Vitoria, Federal University of Pernambuco, Vitoria de Santo Antao, Brazil</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Katoh</surname>
<given-names>Masaru</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>National Cancer Center, JAPAN</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> SB LP RB GA AL.</p></list-item> <list-item><p><bold>Data curation:</bold> SB LP RB.</p></list-item> <list-item><p><bold>Formal analysis:</bold> SB LP RB GA AL.</p></list-item> <list-item><p><bold>Funding acquisition:</bold> SB LP.</p></list-item> <list-item><p><bold>Investigation:</bold> SB LP.</p></list-item> <list-item><p><bold>Methodology:</bold> SB LP RB GA AL.</p></list-item> <list-item><p><bold>Project administration:</bold> SB LP RB.</p></list-item> <list-item><p><bold>Resources:</bold> SB.</p></list-item> <list-item><p><bold>Validation:</bold> SB LP.</p></list-item> <list-item><p><bold>Writing – original draft:</bold> SB LP RB GA AL.</p></list-item> <list-item><p><bold>Writing – review &amp; editing:</bold> SB.</p></list-item></list></p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">salomao.silva@usp.bt</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>11</issue>
<elocation-id>e0165310</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>5</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Bueno et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0165310"/>
<abstract>
<p>Aerobic power (VO<sub>2</sub>max), aerobic capacity (RCP), and running efficiency (RE) are important markers of aerobic fitness. However, the influence of the angiotensin converting enzyme (ACE) polymorphism on these markers has not been investigated in healthy individuals. One hundred and fifty physically active young men (age 25 ± 3 years; height 1.77 ± 0.06 m; body mass 76.6 ± 0.9 kg; VO<sub>2</sub>max 47.7 ± 5.5 ml·kg<sup>-</sup>1·min<sup>-1</sup>) visited the laboratory on two separate occasions, and performed the following tests: a) a maximal incremental treadmill test to determine VO<sub>2</sub>max and RCP, and b) two constant-speed running tests (10 km·h<sup>-1</sup> and 12 km·h<sup>-1</sup>) to determine RE. The genotype frequency was II = 21%; ID = 52%; and DD = 27%. There was a tendency for higher VO<sub>2</sub>max with the ACE II genotype (p = 0.08) compared to DD and ID genotypes. Magnitude based inferences suggested a <italic>likely beneficial effect</italic> on VO<sub>2</sub>max with the ACE II genotype. There was no association between genotypes for other variable. These findings suggest that individuals with the ACE II genotype have a tendency towards better values in aerobic power, but not with aerobic capacity or running economy.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>CAPES</institution>
</funding-source>
<award-id>1182744</award-id>
<principal-award-recipient>Salomão Bueno Silva</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>FAPESP</institution>
</funding-source>
<award-id>2010/13913-6</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Pasqua</surname>
<given-names>Leonardo A</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by CAPES (grant 1182744) (SB) and FAPESP (grant 2010/13913-6) (LP).</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="2"/>
<page-count count="10"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and supporting information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>In the last decade several components of physical fitness have been identified as essential to maintaining healthy life-style [<xref ref-type="bibr" rid="pone.0165310.ref001">1</xref>], including cardiorespiratory endurance and aerobic fitness [<xref ref-type="bibr" rid="pone.0165310.ref002">2</xref>]. Aerobic fitness is related to oxygen transport and utilization [<xref ref-type="bibr" rid="pone.0165310.ref002">2</xref>] and its importance has been associated to cardiovascular system [<xref ref-type="bibr" rid="pone.0165310.ref003">3</xref>]. The most relevant physiological variables related to aerobic fitness include aerobic power, i.e. maximal oxygen uptake (VO<sub>2</sub>max) [<xref ref-type="bibr" rid="pone.0165310.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0165310.ref003">3</xref>], aerobic capacity, i.e. the respiratory compensation point (RCP) [<xref ref-type="bibr" rid="pone.0165310.ref004">4</xref>] and efficiency of energy use during running, i.e. running economy (RE) [<xref ref-type="bibr" rid="pone.0165310.ref005">5</xref>].</p>
<p>It has been demonstrated that aerobic fitness is a result of the interaction between environmental [<xref ref-type="bibr" rid="pone.0165310.ref006">6</xref>] and genetic factors [<xref ref-type="bibr" rid="pone.0165310.ref007">7</xref>]. In particular, a genetic polymorphism in the angiotensin-converting enzyme (ACE) gene might influence endurance [<xref ref-type="bibr" rid="pone.0165310.ref007">7</xref>]. ACE is a key-enzyme in the renin angiotensin system (RAS), influencing the conversion of angiotensin-I (Ang-I) to angiotensin II (Ang-II), the half-life of bradykinin [<xref ref-type="bibr" rid="pone.0165310.ref007">7</xref>] and the hydro-electrolytic control in the human body [<xref ref-type="bibr" rid="pone.0165310.ref008">8</xref>]. The ACE gene polymorphism is characterized by insertion or deletion of the 287 base pair in intron 16, resulting in three genotypes; II, ID, and DD [<xref ref-type="bibr" rid="pone.0165310.ref008">8</xref>]. This polymorphism is associated with different ACE concentrations [<xref ref-type="bibr" rid="pone.0165310.ref006">6</xref>] and related to distinct prevalence in sports [<xref ref-type="bibr" rid="pone.0165310.ref007">7</xref>]. The ACE II genotype is more prevalent in successful endurance athletes, such as mountaineers and rowers, compared to DD and ID ACE genotypes [<xref ref-type="bibr" rid="pone.0165310.ref009">9</xref>]. Furthermore, superior endurance performance of individuals with the ACE II genotype compared to DD may be related to increased aerobic metabolism function [<xref ref-type="bibr" rid="pone.0165310.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0165310.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0165310.ref012">12</xref>]. For instance, studies have demonstrated superior oxygen extraction (a-vO<sub>2</sub> difference), due to the action of vasodilator factors such as bradykinin [<xref ref-type="bibr" rid="pone.0165310.ref010">10</xref>], higher oxygen supply to the exercising muscles provide by higher capillarity in skeletal muscle [<xref ref-type="bibr" rid="pone.0165310.ref011">11</xref>] and a greater energy supply due to a greater concentration of the enzymes and organelles involved in aerobic metabolism [<xref ref-type="bibr" rid="pone.0165310.ref012">12</xref>]. Taken together, these findings suggest that processes related to oxygen consumption may mediate the relationship between the ACE gene polymorphism and aerobic fitness.</p>
<p>Despite this association between the ACE II genotype and success in endurance sports [<xref ref-type="bibr" rid="pone.0165310.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0165310.ref009">9</xref>], few studies have investigated the direct relationship between the ACE genotype and aerobic fitness in healthy individuals [<xref ref-type="bibr" rid="pone.0165310.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0165310.ref013">13</xref>]. It is believed that whole-body physiological variables related to oxygen consumption are influenced by the level of training of the individuals [<xref ref-type="bibr" rid="pone.0165310.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0165310.ref004">4</xref> <xref ref-type="bibr" rid="pone.0165310.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0165310.ref006">6</xref>]. In addition, most studies comparing ACE genotypes and aerobic fitness, such as aerobic power, used relatively small cohorts [<xref ref-type="bibr" rid="pone.0165310.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0165310.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0165310.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0165310.ref016">16</xref>] limiting the interpretation of these results. Thus, it appears logical to suggest that the influence of the ACE genotype on VO<sub>2</sub>max, RCP and RE could be more evident in an increased cohort of non-athletic individuals. Furthermore, previous research has primarily employed cycling tests [<xref ref-type="bibr" rid="pone.0165310.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0165310.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0165310.ref017">17</xref>]. Cycling is influenced by enhanced muscle tension imposed by the muscle contraction [<xref ref-type="bibr" rid="pone.0165310.ref018">18</xref>], which reduces peripheral blood flow and oxygen extraction [<xref ref-type="bibr" rid="pone.0165310.ref019">19</xref>]. Thus, the mechanical aspects of muscle contraction during cycling might influence oxygen consumption, which may affect the relationship between the ACE polymorphism and aerobic power. Therefore, studies aiming to clarify the association between ACE genotypes and variables associated to aerobic fitness may benefit from employing running tests in non-trained individuals.</p>
<p>The present study aimed to investigate the influence of ACE genotypes on cardiorespiratory variables relating to aerobic fitness during running (VO<sub>2</sub>max, RCP and RE). It was hypothesized that individuals with ACE II genotype would have a greater VO<sub>2</sub>max, RCP and RE in comparison to individuals with ID and DD genotypes.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec003">
<title>Participants</title>
<p>One hundred and fifty healthy young males (age 25.0 ± 3.0 years, body mass 76.6 ± 0.9 kg, height 1.77 ± 0.06 m, and body fat 13.5 ± 3.9%) without muscular disease or cardiovascular pathology were recruited. All participants received verbal explanation about the possible benefits, risks, and discomfort associated with the study and gave written informed consent. Procedures were in accordance with the Helsinki declaration of 1975 and approved by the Local Ethics Committee for Human Studies of the University of São Paulo.</p>
</sec>
<sec id="sec004" sec-type="materials|methods">
<title>Experimental Design</title>
<p>The volunteers visited the laboratory on two separate occasions. The first visit consisted of DNA collection, anthropometric measurements and a maximal incremental treadmill test to exhaustion. During the second visit, participants performed two submaximal treadmill tests, separated by six minutes of rest, and completed a short version of the physical activity questionnaire (IPAQ-short version). All tests were performed at the same time of day at a constant room temperature (20–24°C) and 2–3 h following the last meal. The volunteers were asked to refrain from any exhaustive exercise 48 h prior to the tests, and from taking nutritional supplements during the experimental period.</p>
</sec>
<sec id="sec005">
<title>Anthropometric measurements</title>
<p>Anthropometric measurements were taken according to guidelines described by Norton and Olds [<xref ref-type="bibr" rid="pone.0165310.ref020">20</xref>]. Individual body mass was measured on an electronic scale. Height was measured using a stadiometer. Skinfold thickness was measured at seven sites (chest, axilla, triceps, subscapular, abdominal, suprailiac, and thigh) using a Harpenden caliper (West Sussex, UK). The same evaluator took all measurements. The Jackson and Pollock’s [<xref ref-type="bibr" rid="pone.0165310.ref021">21</xref>] equation was used to estimate body density and Brozek et al. [<xref ref-type="bibr" rid="pone.0165310.ref022">22</xref>] equation was used to estimate body fat.</p>
</sec>
<sec id="sec006">
<title>Maximal incremental treadmill test</title>
<p>The participants performed a maximal incremental running test on a motor-driven treadmill (TK35, CEFISE, Nova Odessa, Brazil) to determine VO<sub>2</sub>max and RCP. Following a 3-min warm-up at 8 km·h<sup>-1</sup>, speed was increased by 1 km·h<sup>-1</sup> every minute until exhaustion, which was defined as the individual’s inability to maintain the running pace. Participants received strong verbal encouragement to ensure they continued as long as possible. Gas exchanges were measured breath-by-breath throughout the exercise using a gas analyzer (Cortex Metamax 3B, Cortex Biophysik, Leipzig, Germany) and subsequently averaged over 30-s intervals. Heart rate was monitored during the test using a heart rate transmitter (Polar <sup>®</sup>Beat, Kemple, Finland) coupled to the gas analyzer. VO<sub>2</sub>max was determined when two or more of the following criteria were met: an increase in VO<sub>2</sub> of less than 2.1 ml·kg<sup>-1</sup>·min<sup>-1</sup> between two consecutive stages [<xref ref-type="bibr" rid="pone.0165310.ref023">23</xref>]; a respiratory exchange ratio greater than 1.1 [<xref ref-type="bibr" rid="pone.0165310.ref023">23</xref>]; and a heart rate within 10 bpm of the maximal estimated heart rate of 220-age [<xref ref-type="bibr" rid="pone.0165310.ref023">23</xref>]. Maximal heart rate was defined as the highest value obtained during the test (HR<sub>MAX</sub>). Three independent investigators determined the RCP by a nonlinear increase in VE/VCO<sub>2</sub>, a constant increase in VE/VO<sub>2</sub>, and a first decrease in the expiratory fraction of CO<sub>2</sub> [<xref ref-type="bibr" rid="pone.0165310.ref004">4</xref>].</p>
</sec>
<sec id="sec007">
<title>Submaximal test</title>
<p>Participants performed two submaximal runs at 10 km·h<sup>-1</sup> and 12 km·h<sup>-1</sup> for 6 min interspersed by a 6-min interval. The device used to measure the VO<sub>2</sub> was the same used for the incremental test. The RE was calculated as the mean VO<sub>2</sub> over the last 30-s of each exercise speed [<xref ref-type="bibr" rid="pone.0165310.ref005">5</xref>].</p>
</sec>
<sec id="sec008">
<title>DNA extraction</title>
<p>The cells for DNA extraction were obtained via mouthwash. Cells were submitted to an overnight digestion with proteinase K. Nucleotides were separated from the cellular debris by density gradient centrifugation using chloroform. Genomic DNA was precipitated with isopropyl alcohol, isolated by centrifugation and resuspended in TE buffer. DNA quantification was performed using a spectrophotometer (NanoDrop, ND 2000, USA), and the concentration was adjusted to 1 μg.μL<sup>-1</sup> for subsequent storage in -20°C.</p>
<p>ACE gene polymorphisms were determined in PCR-real time (Polymerase Chain Reaction) by 3-primer PCR described previously (ACE-1: <monospace>5'-CATCCTTTCTCCCATTTCTC-3'</monospace>; ACE-2: <monospace>5'-TGGGATTACAGGCGTGATACAG-3'</monospace> and ACE-3: <monospace>5'-ATTCAGAGCTGGAATAAAATT-3'</monospace>). The Platinum SYBR-green reagent (Life Technologies<sup>®</sup>) was utilized for amplification of the insertion or deletion genotypes. The SYBER-green fluoresces is quantified from the dissociation curve, with allele I showing dissociation at approximately 73°C, allele D at approximately 76°C and subjects with two alleles submit two dissociation temperatures (73°C and 76°C).</p>
</sec>
<sec id="sec009">
<title>Statistical Analysis</title>
<p>Participants were separated according to ACE genotypes (II, ID or DD). Hardy-Weinberg equilibrium was tested using the <italic>chi-square test</italic>. Data normality was assessed via the Kolmogorov-Smirnov test. Because all variables showed a normal distribution, data are reported as means and standard deviations (±SD) and parametric tests applied. One-way analysis of variance (ANOVA) was used to compare the effects of the ACE genotype on VO<sub>2</sub>max, RCP, and RE. The significance level was set at α ≤ 0.05 and all statistical analyses were performed using SPSS (version 13.0; Chicago, IL).</p>
<p>In addition, the smallest worthwhile effects were calculated for each physiological variable between pairs of genotype (II <italic>vs</italic> DD, II <italic>vs</italic> ID, DD <italic>vs</italic> ID) to determine the likelihood that the effect was substantially beneficial, trivial or detrimental [<xref ref-type="bibr" rid="pone.0165310.ref024">24</xref>]. Quantitative chances of beneficial effects were assessed qualitatively as follows: &lt;1% almost certainly not, 1–5% very unlikely, 5–25% unlikely, 25–75% possible, 75–95% likely, 95–99 very likely, and &gt;99% almost certain. Furthermore, if the chance of having beneficial and detrimental effect were both &gt; 5%, the true difference was assessed as unclear [<xref ref-type="bibr" rid="pone.0165310.ref024">24</xref>].</p>
</sec>
</sec>
<sec id="sec010" sec-type="results">
<title>Results</title>
<p>The genotype frequencies attained using the Hardy-Weinberg Equilibrium were: II = 21%; ID = 52%; DD = 27%. The frequency of the ACE genotype was similar to that reported previously in a Caucasian population[<xref ref-type="bibr" rid="pone.0165310.ref021">21</xref>]. Participants’ characteristics were similar between groups (p &gt; 0.05) (<xref ref-type="table" rid="pone.0165310.t001">Table 1</xref>). Level of physical activity was classified as moderately active in accordance with mean values of the IPAQ-SV outcomes (<xref ref-type="table" rid="pone.0165310.t001">Table 1</xref>).</p>
<table-wrap id="pone.0165310.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0165310.t001</object-id>
<label>Table 1</label> <caption><title>Anthropometric characteristics, physical activity level, and physiological variables of the participants (n = 150).</title></caption>
<alternatives>
<graphic id="pone.0165310.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0165310.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left"/>
<th align="center">DD (n = 41)</th>
<th align="center">ID (n = 77)</th>
<th align="center">II (n = 32)n = 32</th>
<th align="left"><italic>p Value</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>Age (years)</bold></td>
<td align="center" style="background-color:#F2F2F2">24 ± 4</td>
<td align="center" style="background-color:#F2F2F2">25 ± 3</td>
<td align="center" style="background-color:#F2F2F2">26 ± 3</td>
<td align="char" char="." style="background-color:#F2F2F2">0.12</td>
</tr>
<tr>
<td align="left"><bold>Mass (kg)</bold></td>
<td align="center">75.8 ± 8.9</td>
<td align="center">78.1 ± 9.7</td>
<td align="center">73.9 ± 8.3</td>
<td align="char" char=".">0.07</td>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>Heights (cm)</bold></td>
<td align="center" style="background-color:#F2F2F2">177.4 ± 5.1</td>
<td align="center" style="background-color:#F2F2F2">177.2 ± 5.9</td>
<td align="center" style="background-color:#F2F2F2">175.2 ± 4.8</td>
<td align="char" char="." style="background-color:#F2F2F2">0.16</td>
</tr>
<tr>
<td align="left"><bold>Body fat (%)</bold></td>
<td align="center">13.1 ± 4.3</td>
<td align="center">14 ± 3.8</td>
<td align="center">13 ± 3.6</td>
<td align="char" char=".">0.27</td>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2"><bold>IPAQ-SV (score)</bold></td>
<td align="center" style="background-color:#F2F2F2">1320 ± 120</td>
<td align="center" style="background-color:#F2F2F2">1298 ± 134</td>
<td align="center" style="background-color:#F2F2F2">1302 ± 153</td>
<td align="char" char="." style="background-color:#F2F2F2">0.72</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>IPAQ-SV: international physical activity questionnaire—short version</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Figures shows the comparisons of VO<sub>2</sub>max (<xref ref-type="fig" rid="pone.0165310.g001">Fig 1</xref>), RCP (<xref ref-type="fig" rid="pone.0165310.g002">Fig 2</xref>), RE<sub>10km.h</sub><sup>-1</sup>(<xref ref-type="fig" rid="pone.0165310.g003">Fig 3</xref>), and RE<sub>12km.h</sub><sup>-1</sup> (<xref ref-type="fig" rid="pone.0165310.g004">Fig 4</xref>) for each ACE genotype. There was a trend towards higher VO<sub>2</sub>max values in the ACE II genotype compared to the DD and ID genotypes (p = 0.086). There were no statistical differences between genotypes for RCP, RE<sub>10km.h</sub><sup>-1</sup>, and RE<sub>12km.h</sub><sup>-1</sup> (all p &gt; 0.05).</p>
<fig id="pone.0165310.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0165310.g001</object-id>
<label>Fig 1</label>
<caption>
<title>VO<sub>2</sub>max.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0165310.g001" xlink:type="simple"/>
</fig>
<fig id="pone.0165310.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0165310.g002</object-id>
<label>Fig 2</label>
<caption>
<title>RCP.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0165310.g002" xlink:type="simple"/>
</fig>
<fig id="pone.0165310.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0165310.g003</object-id>
<label>Fig 3</label>
<caption>
<title>RE at 10 km.h<sup>-1</sup>.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0165310.g003" xlink:type="simple"/>
</fig>
<fig id="pone.0165310.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0165310.g004</object-id>
<label>Fig 4</label>
<caption>
<title>12 km.h<sup>-1</sup>.</title>
<p>Comparison between ACE DD, ID and II genotypes. VO<sub>2</sub>max: maximal oxygen uptake; RCP: running speed of respiratory compensation threshold; RE<sub>10km.h</sub><sup>-1</sup>: running economy at 10 km.h<sup>-1</sup>; RE<sub>12km.h</sub><sup>-1</sup>: running economy at 12 km.h<sup>-1</sup>.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0165310.g004" xlink:type="simple"/>
</fig>
<p><xref ref-type="table" rid="pone.0165310.t002">Table 2</xref> shows the chances of a beneficial/trivial/ detrimental effect for each physiological marker between ACE genotypes. Comparison of VO<sub>2</sub>max between ACE II and DD genotypes showed an 88% likelihood of being beneficial, 9% trivial and 3% harmful for ACE II. These data demonstrate a likely beneficial effect of the ACE II genotype on VO<sub>2</sub>max (<xref ref-type="table" rid="pone.0165310.t002">Table 2</xref>). For all other comparisons, unclear effects were obtained.</p>
<table-wrap id="pone.0165310.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0165310.t002</object-id>
<label>Table 2</label> <caption><title>The chance of likelihood effect for each cardiorespiratory variables.</title></caption>
<alternatives>
<graphic id="pone.0165310.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0165310.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center"/>
<th align="center">The chance of genotype being beneficial (%)</th>
<th align="center">The chance of genotype being trivial (%)</th>
<th align="center">The chance of genotype being detrimental (%)</th>
<th align="center">Qualitative descriptor</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" style="background-color:#F2F2F2"><bold>VO<sub>2</sub>max</bold></td>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
</tr>
<tr>
<td align="center"><bold>II vs DD</bold></td>
<td align="center">88</td>
<td align="center">9</td>
<td align="center">3</td>
<td align="center">Likely-Beneficial</td>
</tr>
<tr>
<td align="center" style="background-color:#F2F2F2"><bold>II vs ID</bold></td>
<td align="center" style="background-color:#F2F2F2">52</td>
<td align="center" style="background-color:#F2F2F2">32</td>
<td align="center" style="background-color:#F2F2F2">16</td>
<td align="center" style="background-color:#F2F2F2">Possible-Unclear</td>
</tr>
<tr>
<td align="center"><bold>ID vs DD</bold></td>
<td align="center">16</td>
<td align="center">32</td>
<td align="center">52</td>
<td align="center">Possibly-Unclear</td>
</tr>
<tr>
<td align="center" style="background-color:#F2F2F2"><bold>RCP</bold></td>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
</tr>
<tr>
<td align="center"><bold>II vs DD</bold></td>
<td align="center">15</td>
<td align="center">81</td>
<td align="center">1</td>
<td align="center">Likely-Trivial</td>
</tr>
<tr>
<td align="center" style="background-color:#F2F2F2"><bold>II vs ID</bold></td>
<td align="center" style="background-color:#F2F2F2">10</td>
<td align="center" style="background-color:#F2F2F2">89</td>
<td align="center" style="background-color:#F2F2F2">1</td>
<td align="center" style="background-color:#F2F2F2">Likely-Trivial</td>
</tr>
<tr>
<td align="center"><bold>ID vs DD</bold></td>
<td align="center">0</td>
<td align="center">72</td>
<td align="center">28</td>
<td align="center">Possible-Trivial</td>
</tr>
<tr>
<td align="center" style="background-color:#F2F2F2"><bold>RE<sub>10km.h</sub><sup>-1</sup></bold></td>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
</tr>
<tr>
<td align="center"><bold>II vs DD</bold></td>
<td align="center">26</td>
<td align="center">47</td>
<td align="center">27</td>
<td align="center">Possible-Trivial</td>
</tr>
<tr>
<td align="center" style="background-color:#F2F2F2"><bold>II vs ID</bold></td>
<td align="center" style="background-color:#F2F2F2">28</td>
<td align="center" style="background-color:#F2F2F2">62</td>
<td align="center" style="background-color:#F2F2F2">10</td>
<td align="center" style="background-color:#F2F2F2">Possible-Trivial</td>
</tr>
<tr>
<td align="center"><bold>ID vs DD</bold></td>
<td align="center">0</td>
<td align="center">72</td>
<td align="center">28</td>
<td align="center">Possible-Trivial</td>
</tr>
<tr>
<td align="center" style="background-color:#F2F2F2"><bold>RE<sub>12km.h</sub><sup>-1</sup></bold></td>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
<td align="center" style="background-color:#F2F2F2"/>
</tr>
<tr>
<td align="center"><bold>II vs DD</bold></td>
<td align="center">46</td>
<td align="center">43</td>
<td align="center">11</td>
<td align="center">Possible -Unclear</td>
</tr>
<tr>
<td align="center" style="background-color:#F2F2F2"><bold>II vs ID</bold></td>
<td align="center" style="background-color:#F2F2F2">34</td>
<td align="center" style="background-color:#F2F2F2">48</td>
<td align="center" style="background-color:#F2F2F2">18</td>
<td align="center" style="background-color:#F2F2F2">Possible-Trivial</td>
</tr>
<tr>
<td align="center"><bold>ID vs DD</bold></td>
<td align="center">09</td>
<td align="center">51</td>
<td align="center">40</td>
<td align="center">Possible-Trivial</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec011" sec-type="conclusions">
<title>Discussion</title>
<p>Previous research has suggested that the ACE polymorphism might be a relevant genetic factor for aerobic fitness in humans [<xref ref-type="bibr" rid="pone.0165310.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0165310.ref017">17</xref>], specifically that the ACE II genotype might have beneficial effects on oxygen consumption [<xref ref-type="bibr" rid="pone.0165310.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0165310.ref013">13</xref>]. The major finding of this study was that individuals with the ACE II genotype showed an 88% likelihood of having a higher VO<sub>2</sub>max compared to the DD genotype.</p>
<p>It has been suggested that genetic factors may influence up to 50% of the variability of the individual training-induced increases in aerobic power [<xref ref-type="bibr" rid="pone.0165310.ref025">25</xref>, <xref ref-type="bibr" rid="pone.0165310.ref026">26</xref>]. In particular, the ACE polymorphism has been considered as one of the most relevant [<xref ref-type="bibr" rid="pone.0165310.ref007">7</xref>]. It has been demonstrated that lower concentrations of ACE, common in the ACE II genotype, influences the half-life and concentration of bradykinin [<xref ref-type="bibr" rid="pone.0165310.ref012">12</xref>]. Individuals carrying these genotypes, due to the higher concentration of bradykinin, have a better vessel permeability [<xref ref-type="bibr" rid="pone.0165310.ref010">10</xref>] and oxygen supply [<xref ref-type="bibr" rid="pone.0165310.ref025">25</xref>]. Therefore, it is believed that increased oxygen availability to the skeletal muscle during exercise contributes to an increased VO<sub>2</sub>max [<xref ref-type="bibr" rid="pone.0165310.ref010">10</xref>]. Support for this hypothesis was shown by Hagberg et al. [<xref ref-type="bibr" rid="pone.0165310.ref010">10</xref>], who showed that postmenopausal women with the ACE II genotype had greater VO<sub>2</sub>max values than their DD or ID genotype counterparts. These authors also showed that the greater VO<sub>2</sub>max values were associated with higher arteriovenous oxygen differences in II genotype compared to the other two ACE genotypes. Similarly, in the present study, individuals with the ACE II genotype tended to have a greater aerobic power compared to individuals with ID and DD genotypes. These differences were shown to be beneficial as suggested by magnitude based inferences (88% vs. DD).</p>
<p>Controversially, there are some findings indicating that the ACE DD genotype influences VO<sub>2</sub>max in healthy adults [<xref ref-type="bibr" rid="pone.0165310.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0165310.ref021">21</xref>], while others have not demonstrated any association between ACE genotypes and VO<sub>2</sub>max [<xref ref-type="bibr" rid="pone.0165310.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0165310.ref027">27</xref>]. For instance, Vaughan et al. [<xref ref-type="bibr" rid="pone.0165310.ref012">12</xref>] and Zhao et al. [<xref ref-type="bibr" rid="pone.0165310.ref014">14</xref>] showed that individuals with ACE DD genotype have a greater VO<sub>2</sub>max than those with the ACE II genotype. These results occur primarily because the ACE DD genotype is related to left ventricle hypertrophy (LVH) [<xref ref-type="bibr" rid="pone.0165310.ref014">14</xref>] and LVH has been shown to be positively correlated tocardiac output leading to possible benefits in endurance performance [<xref ref-type="bibr" rid="pone.0165310.ref006">6</xref>]. Nevertheless, it is well known that increased LVH does not represent an increase in VO<sub>2</sub>max More studies are necessary to confirm this association with ACE genotype [<xref ref-type="bibr" rid="pone.0165310.ref007">7</xref>].</p>
<p>It is important to emphasize that Rankinen et al. [<xref ref-type="bibr" rid="pone.0165310.ref016">16</xref>], Vaughan et al. [<xref ref-type="bibr" rid="pone.0165310.ref012">12</xref>] and Day et al. [<xref ref-type="bibr" rid="pone.0165310.ref027">27</xref>] determined VO<sub>2</sub>max on a cycle ergometer, which requires increased concentric muscle contraction [<xref ref-type="bibr" rid="pone.0165310.ref018">18</xref>]. It has been shown that critical occlusion of blood flow occurs at approximately 45–60% of maximal voluntary contraction [<xref ref-type="bibr" rid="pone.0165310.ref028">28</xref>]. Thus, a higher percentage of maximal voluntary contraction is required during cycling as compared to running [<xref ref-type="bibr" rid="pone.0165310.ref019">19</xref>], which could mechanically reduce peripheral blood flow and oxygen availability. Therefore, while the exact mechanisms that underlie the differences between the current and previous studies have not been completely elucidated, it is plausible to assume that the ACE II genotype may have an important role in oxygen delivery to the exercising muscle in physically active individuals, which results in elevated values of aerobic power.</p>
<p>Studies have shown that the ACE polymorphism influences metabolic [<xref ref-type="bibr" rid="pone.0165310.ref011">11</xref>], and peripheral muscle adaptation [<xref ref-type="bibr" rid="pone.0165310.ref029">29</xref>]; individuals with the ACE II genotype present differences in muscle fiber distribution [<xref ref-type="bibr" rid="pone.0165310.ref011">11</xref>] and concentration of aerobic-associated enzymes [<xref ref-type="bibr" rid="pone.0165310.ref012">12</xref>]. Zang et al. [<xref ref-type="bibr" rid="pone.0165310.ref029">29</xref>] compared muscle fiber composition in individuals with the II, ID and DD ACE polymorphism and showed that individuals with the II genotype showed a greater quantity of type IA fibers than ID ad DD. Similarly, Vaughan et al. [<xref ref-type="bibr" rid="pone.0165310.ref012">12</xref>] found that individuals with the II genotype show a modulation in capillary supply lines, resulting in beneficial adjusts to lipid metabolism. Therefore, individuals with the ACE II genotype seem to be more susceptible to peripheral adaptations compared to DD or ID genotypes [<xref ref-type="bibr" rid="pone.0165310.ref013">13</xref>]. It could thus be expected that these peripheral differences would influence submaximal physiological variables such as energy cost and aerobic capacity [<xref ref-type="bibr" rid="pone.0165310.ref017">17</xref>]. Williams et al. [<xref ref-type="bibr" rid="pone.0165310.ref013">13</xref>] found that individuals with the ACE II genotype had a higher delta efficiency, which was estimated as the percentage ratio of the change in work performed per minute to the change in energy expended per minute. This indicates that individuals with the ACE II genotype are energetically more economical than individuals with other ACE genotypes. However, the results of the present study showed no differences in variables related to aerobic capacity or running economy during running (i.e. RCP, RE<sub>10km/h</sub>, and RE<sub>12km/h</sub>) between the three ACE genotypes. These findings are in agreement with the results of Gomez-Gallego et al. [<xref ref-type="bibr" rid="pone.0165310.ref017">17</xref>] and Orysiak et al. [<xref ref-type="bibr" rid="pone.0165310.ref030">30</xref>], who showed no differences between ACE genotypes for power output at the ventilatory threshold and RCP in athletes. Taken together, the findings of the current study suggest that, in the present cohort, the ACE genotypes did not influence the submaximal variables important to aerobic fitness that were measured.</p>
</sec>
<sec id="sec012" sec-type="conclusions">
<title>Conclusion</title>
<p>In conclusion, the results of the current study showed that individuals with the ACE II genotype tended to have a greater VO<sub>2</sub>max compared to individuals with the ACE DD genotype. Despite this, the ACE genotypes did not appear to have any influence on submaximal variables related to physical fitness. Thus, further studies are required to clarify the influence of the ACE polymorphism in submaximal variables related to aerobic fitness.</p>
</sec>
<sec id="sec013">
<title>Supporting Information</title>
<supplementary-material id="pone.0165310.s001" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0165310.s001" xlink:type="simple">
<label>S1 Supporting Information</label>
<caption>
<title/>
<p>(XLSX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>Salomão Bueno is supported by CAPES (grant 1182744). Leonardo A. Pasqua is supported by FAPESP (grant 2010/13913-6).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0165310.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garber</surname> <given-names>CE</given-names></name>, <name name-style="western"><surname>Blissmer</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Deschenes</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Franklin</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Lamonte</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>IM</given-names></name>, <name name-style="western"><surname>Nieman</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Swain</surname> <given-names>DP</given-names></name>; <collab>American College of Sports Medicine</collab>. <article-title>American College of Sports Medicine position stand. (2011) Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise</article-title>. <source>Med Sci Sports Exerc</source>. <volume>43</volume>(<issue>7</issue>):<fpage>1334</fpage>–<lpage>59</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1249/MSS.0b013e318213fefb" xlink:type="simple">10.1249/MSS.0b013e318213fefb</ext-link></comment> <object-id pub-id-type="pmid">21694556</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Caspersen</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Powell</surname> <given-names>KE</given-names></name>, <name name-style="western"><surname>Christenson</surname> <given-names>GM</given-names></name>. (<year>1985</year>). <article-title>Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research</article-title>. <source>Public Health Rep</source>. <volume>100</volume>(<issue>2</issue>):<fpage>126</fpage>–<lpage>31</lpage>. <object-id pub-id-type="pmid">3920711</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bassett</surname> <given-names>D.R.</given-names> <suffix>Jr</suffix></name>, <name name-style="western"><surname>Howley</surname></name>. (<year>2000</year>). <article-title>Limiting factors for maximum oxygen uptake and eterminants of endurance performance</article-title>. <source>Medicine and Science in Sports and Exercise</source>, <volume>32</volume> (<issue>1</issue>):<fpage>70</fpage>–<lpage>78</lpage>. <object-id pub-id-type="pmid">10647532</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meyer</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Lucía</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Earnest</surname> <given-names>CP</given-names></name>, <etal>et al</etal>.(<year>2004</year>). <article-title>A conceptual framework for performance diagnosis and training prescription from submaximal gas exchange parameters—theory and application</article-title>. <source>International Journal of Sports Medicine</source>, 20005, 26, <volume>26</volume> <issue>Suppl 1</issue>:<fpage>S38</fpage>–<lpage>48</lpage>.</mixed-citation></ref>
<ref id="pone.0165310.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saunders</surname> <given-names>PU</given-names></name>, <name name-style="western"><surname>Pyne</surname> <given-names>DB</given-names></name>, <name name-style="western"><surname>Telford</surname> <given-names>RD</given-names></name>, <etal>et al</etal>. (<year>2000</year>). <article-title>Factors affecting running economy in trained distance runners</article-title>. <source>Sports Med</source>, <volume>34</volume> (<issue>7</issue>):<fpage>465</fpage>–<lpage>485</lpage>.</mixed-citation></ref>
<ref id="pone.0165310.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Myburgh</surname> <given-names>KH</given-names></name>. (<year>2003</year>). <article-title>What makes an endurance athlete world-class? Not simply a physiological conundrum</article-title>. <source>Comparative Biochemistry Physiology A Molecular Integrative Physiology</source>, <volume>136</volume> (<issue>1</issue>):<fpage>171</fpage>–<lpage>190</lpage>. <object-id pub-id-type="pmid">14527639</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Puthucheary</surname> <given-names>Z.</given-names></name> <name name-style="western"><surname>Skipworth</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Rawal</surname> <given-names>J</given-names></name>, <etal>et al</etal>. (<year>2010</year>). <article-title>The ACE gene and human performance: 12 years on</article-title>. <source>Sports Medicine</source>, <volume>41</volume>:<fpage>433</fpage>–<lpage>448</lpage>.</mixed-citation></ref>
<ref id="pone.0165310.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Montgomery</surname> <given-names>HE</given-names></name>, <name name-style="western"><surname>Clarkson</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Dollery</surname> <given-names>CM</given-names></name>, <etal>et al</etal>. (<year>1997</year>). <article-title>Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training</article-title>. <source>Circulation</source>, <volume>96</volume> (<issue>3</issue>): <fpage>741</fpage>–<lpage>747</lpage>. <object-id pub-id-type="pmid">9264477</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Montgomery</surname> <given-names>HE</given-names></name>. <name name-style="western"><surname>Marshall</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hemingway</surname> <given-names>H</given-names></name>, <etal>et al</etal>. (<year>1998</year>). <article-title>Human gene for physical performance</article-title>. <source>Nature</source>. <volume>393</volume>: <fpage>212</fpage>.</mixed-citation></ref>
<ref id="pone.0165310.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hagberg</surname> <given-names>JM</given-names></name>. <name name-style="western"><surname>McCole</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>MD</given-names></name>, <etal>et al</etal>. (<year>2002</year>). <article-title>ACE insertion/deletion polymorphism and submaximal exercise hemodynamics in postmenopausal women</article-title>. <source>Journal of Applied Physiology</source>, <volume>92</volume>:<fpage>1083</fpage>–<lpage>1088</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/japplphysiol.00135.2001" xlink:type="simple">10.1152/japplphysiol.00135.2001</ext-link></comment> <object-id pub-id-type="pmid">11842043</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Tanaka</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Shono</surname> <given-names>N</given-names></name>, <etal>et al</etal>. (<year>2003</year>). <article-title>The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle</article-title>. <source>Clinical Genetic</source>, <volume>62</volume>:<fpage>139</fpage>–<lpage>144</lpage>.</mixed-citation></ref>
<ref id="pone.0165310.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vaughan</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Huber-Abel</surname> <given-names>FA</given-names></name>, <name name-style="western"><surname>Graber</surname> <given-names>F</given-names></name>, <etal>et al</etal>. (<year>2013</year>). <article-title>The angiotensin converting enzyme insertion/deletion polymorphism alters the response of muscle energy supply lines to exercise</article-title>. <source>European Journal of Applied Physiology</source>, <volume>v.113</volume>, <issue>n.7</issue>, p.<fpage>1719</fpage>–<lpage>1729</lpage>.</mixed-citation></ref>
<ref id="pone.0165310.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Williams</surname> <given-names>A.G</given-names></name>, <name name-style="western"><surname>Rayson</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Jubb</surname> <given-names>M</given-names></name>, <etal>et al</etal>. (<year>2000</year>). <article-title>ACE gene and muscle performance</article-title>. <source>Nature</source>, 1:<volume>403</volume>:<fpage>614</fpage>.</mixed-citation></ref>
<ref id="pone.0165310.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhao</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Moochhala</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Tham</surname> <given-names>Sy</given-names></name>, <etal>et al</etal>. <article-title>Relationship between angiotensin-converting enzyme ID polymorphism and VO(2max) of Chinese males</article-title>. <source>Life Sci</source>.<volume>73</volume>(<issue>20</issue>):<fpage>2625</fpage>–<lpage>30</lpage>, <year>2003</year>. <object-id pub-id-type="pmid">12967686</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Almeida</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Boullosa</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Pardono</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>The influence of ACE genotype on cardiovascular fitness of moderately active young men</article-title>. <source>Arq Bras Cardiol</source>. <volume>298</volume>(<issue>4</issue>):<fpage>315</fpage>–<lpage>20</lpage>, <year>2012</year>.</mixed-citation></ref>
<ref id="pone.0165310.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rankinen</surname> <given-names>T.</given-names></name> <name name-style="western"><surname>Wolfarth</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Simoneau</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. (<year>2000</year>). <article-title>No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status</article-title>. <source>Journal of Applied Physiology</source>, <volume>88</volume>:<fpage>1571</fpage>–<lpage>1575</lpage>. <object-id pub-id-type="pmid">10797114</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gomez-Gallego</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Santiago</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>González-Freire</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Muniesa</surname> <given-names>CA</given-names></name>, <etal>et al</etal>. (<year>2009</year>). <article-title>Endurance performance: genes or gene combinations?</article-title> <source>International Journal Sports Medicine</source>, <volume>30</volume>: <fpage>66</fpage>–<lpage>72</lpage>.</mixed-citation></ref>
<ref id="pone.0165310.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bijker</surname> <given-names>K.E</given-names></name>, <name name-style="western"><surname>de Groot</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Hollander</surname> <given-names>AP</given-names></name>. (<year>2002</year>). <article-title>Differences in leg muscle activity during running and cycling in humans</article-title>. <source>European Journal of Applied Physiology</source>, <volume>87</volume>(<issue>6</issue>):<fpage>556</fpage>–<lpage>561</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00421-002-0663-8" xlink:type="simple">10.1007/s00421-002-0663-8</ext-link></comment> <object-id pub-id-type="pmid">12355196</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Støren</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Helgerud</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Støa</surname> <given-names>EM</given-names></name>, <etal>et al</etal>. (<year>2008</year>). <article-title>Maximal strength training improves running economy in distance runners</article-title>. <source>Medicine and Science in Sports and Exercise</source>, <volume>40</volume> (<issue>6</issue>):<fpage>1087</fpage>–<lpage>1092</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1249/MSS.0b013e318168da2f" xlink:type="simple">10.1249/MSS.0b013e318168da2f</ext-link></comment> <object-id pub-id-type="pmid">18460997</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref020"><label>20</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Norton</surname></name> and <name name-style="western"><surname>Olds</surname></name> (<year>1996</year>) (eds) <source>Anthropometrica</source>. <publisher-name>University of New South Wale Press</publisher-name>, <publisher-loc>Sydney</publisher-loc>.</mixed-citation></ref>
<ref id="pone.0165310.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jackson</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Pollock</surname> <given-names>ML</given-names></name> (<year>1985</year>) <article-title>Practical assessment of body composition</article-title>. <source>The Physican and Sportsmedicine</source>. <volume>19</volume>: <fpage>76</fpage>–<lpage>90</lpage></mixed-citation></ref>
<ref id="pone.0165310.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brozek</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Grande</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Keys</surname> <given-names>A</given-names></name> (<year>1963</year>). <article-title>Densitometric analysis of body composition: revision of some quantitative assumptions</article-title>. <source>Ann NY Acad Sci</source> <volume>110</volume>: <fpage>113</fpage>–<lpage>140</lpage>. <object-id pub-id-type="pmid">14062375</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Howley</surname> <given-names>ET</given-names></name>, <name name-style="western"><surname>Bassett</surname> <given-names>DR</given-names> <suffix>Jr</suffix></name>, <name name-style="western"><surname>Welch</surname> <given-names>HG</given-names></name>. (<year>1995</year>). <article-title>Criteria for maximal oxygen uptake: review and commentary</article-title>. <source>Medicine and Science in Sports and Exercise</source>, <volume>27</volume>(<issue>9</issue>):<fpage>1292</fpage>–<lpage>1301</lpage>. <object-id pub-id-type="pmid">8531628</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hopkins</surname> <given-names>WG</given-names></name>, <name name-style="western"><surname>Marshall</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Batterham</surname> <given-names>AM</given-names></name>, <etal>et al</etal>. (<year>2009</year>). <article-title>Progressive statistics for studies in sports medicine and exercise science</article-title>. <source>Medicine and Science in Sports and Exercise</source>, <volume>41</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1249/MSS.0b013e31818cb278" xlink:type="simple">10.1249/MSS.0b013e31818cb278</ext-link></comment> <object-id pub-id-type="pmid">19092709</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hamel</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Simoneau</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Lortie</surname> <given-names>G</given-names></name>, <etal>et al</etal>. (<year>1986</year>). <article-title>Heredity and muscle adaptation to endurance training</article-title>. <source>Medicine and Science in Sports and Exercise</source>, <month>Dec</month>;<volume>18</volume>(<issue>6</issue>):<fpage>690</fpage>–<lpage>696</lpage>. <object-id pub-id-type="pmid">3784881</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bouchard</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>A</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Rice</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Skinner</surname> <given-names>JS</given-names></name>, <etal>et al</etal>. <article-title>Familial aggregation of VO (2max) response to exercise training: results from the HERITAGE Family Study</article-title>. (<year>1999</year>). <source>Journal of Applied Physiology</source>, <volume>87</volume> (<issue>3</issue>):<fpage>1003</fpage>–<lpage>1008</lpage>. <object-id pub-id-type="pmid">10484570</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Day</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Gohlke</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Willians</surname> <given-names>AG</given-names></name>. (<year>2007</year>). <article-title>No correlation between circulating ACE activity and VO2max in women</article-title>. <source>European Journal of Applied Physiology</source>, <volume>99</volume>:<fpage>11</fpage>–<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00421-006-0309-3" xlink:type="simple">10.1007/s00421-006-0309-3</ext-link></comment> <object-id pub-id-type="pmid">17006710</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Heyward</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>McCreary</surname> <given-names>L</given-names></name>. (<year>1978</year>). <article-title>Comparison of the relative endurance and critical occluding tension levels of men and women</article-title>. <source>Res Q</source>, <month>Oct</month>;<volume>49</volume>(<issue>3</issue>):<fpage>301</fpage>–<lpage>307</lpage>.</mixed-citation></ref>
<ref id="pone.0165310.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Shono</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Fan</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Ando</surname> <given-names>S</given-names></name>, <etal>et al</etal>. (<year>2005</year>). <article-title>Histochemical characteristics of soleus muscle in angiotensin-converting enzyme gene knockout mice</article-title>. <source>Hypertension Research</source>, <volume>28</volume> (<issue>8</issue>): <fpage>681</fpage>–<lpage>688</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1291/hypres.28.681" xlink:type="simple">10.1291/hypres.28.681</ext-link></comment> <object-id pub-id-type="pmid">16392773</object-id></mixed-citation></ref>
<ref id="pone.0165310.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Orysiak</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zmijewski</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Klusiewicz</surname> <given-names>A</given-names></name>, <etal>et al</etal>. (<year>2013</year>). <article-title>The association between ace gene variation and aerobic capacity in winter endurance disciplines</article-title>. <source>Biology of Sport</source>, <volume>30</volume> (<issue>4</issue>):<fpage>249</fpage>–<lpage>253</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5604/20831862.1077549" xlink:type="simple">10.5604/20831862.1077549</ext-link></comment> <object-id pub-id-type="pmid">24795498</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>